Aytu BioPharma, Inc.

NASDAQ:AYTU

2.29 (USD) • At close October 17, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

202420232022202120202019201820172016201520142013201220112010200920082007
Omzet 81.002107.39996.66965.63227.6327.323.663.2222.5620.2620.0590.0020.002000.00200
Kosten van de omzet 26.41640.76744.38636.4327.5532.2022.0511.4170.9570.0880-0.048000000
Brutowinst 54.58666.63252.28329.220.0795.1181.6091.8041.6050.1740.0590.050.002000.00200
Brutowinstmarge 0.6740.620.5410.4450.7270.6990.440.560.6260.663128.571100100
Onderzoek- en ontwikkelingskosten 2.7914.09514.4395.6231.7210.5890.1681.3486.323.4234.0592.756000000
Algemene en administratieve kosten 22.51428.6331.16725.519.657017.73217.6088.8254.3832.3470.0480.0580.1290.0540.0550.0550
Verkoop- en marketingkosten 26.95841.44838.71330.30811.40300-00000000000
Verkoop-, algemene en administratieve kosten 49.47270.07869.8855.80834.80219.2417.73217.6088.8254.3832.3470.0480.0580.1290.0540.0550.0550.047
Overige kosten 0.568-4.7794.0676.0094.492.1366.2781.7090.6650.0050.0060.0060.0070.0040.0030.00300
Bedrijfskosten 57.47578.96188.38667.4441.01421.96519.45320.66415.817.8066.4060.0540.0580.1340.0570.0580.0550.047
Bedrijfsresultaat -5.254-17.06537.215-38.24-20.935-16.847-19.7-20.125-21.704-7.632-6.347-0.052-0.056-0.134-0.057-0.056-0.055-0.047
Bedrijfsresultaat ratio -0.065-0.1590.385-0.583-0.758-2.301-5.383-6.247-8.47-29.155-107.703-29.951-32.20300-31.89800
Totaal overige inkomsten en kosten netto -6.395-4.722-147.498-19.797.315-10.2858.406-1.114-8.484-0.115-0.0460-0.003-0.0030-0.0030.006-0.002
Inkomen voor belasting -14.076-17.051-110.283-58.03-13.621-27.132-10.188-22.508-28.18-7.747-6.392-0.057-0.06-0.137-0.056-0.059-0.049-0.049
Inkomen voor belasting ratio -0.174-0.159-1.141-0.884-0.493-3.706-2.784-6.987-10.997-29.595-108.476-32.753-34.100-33.65400
Belastingkosten 1.768-0.057-0.110.259-9.92120.035-2.1281.1148.484-0.024-0.8140.9110.0030.003-0.0010.0030.0020.002
Nettowinst -15.84-17.05-108.78-58.29-13.62-47.167-10.188-22.508-28.18-7.723-5.579-0.057-0.06-0.137-0.06-0.059-0.057-0.049
Nettowinstmarge -0.196-0.159-1.14-0.888-0.134-6.443-2.784-6.987-10.997-29.503-94.668-32.753-34.100-33.65400
WPA (Winst Per Aandeel) -2.86-5.11-74.01-69.6-60.2-1,210.28-3,061.23-193,194.38-1,294,738.36-551,671.71-619,854.44-7,164.75-7,459.37-17,100.25-10,045-11,778.8-11,434.6-48,954
Verwaterde WPA -2.86-5.11-74.01-69.6-60.2-1,210.28-3,061.23-193,194.38-1,294,738.36-551,671.71-619,854.44-7,164.75-7,459.37-17,100.25-10,045-11,778.8-11,434.6-48,954
EBITDA 5.951-7.59841.282-14.491-24.611-4.37-8.975-14.495-13.33-7.514-6.249-0.047-0.05-0.127-0.048-0.048-0.047-0.04
EBITDA ratio 0.073-0.0710.427-0.221-0.891-0.597-2.452-4.499-5.202-28.704-106.049-27.127-28.68900-27.16500